Toyama Sumika, Nakamura Tomoya, Tominaga Mitsutoshi, Takamori Kenji
Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Graduate School of Medicine, Juntendo University, 2-1-1, Tomioka, Urayasu-shi 279-0021, Chiba, Japan.
Oji Pharma Co., Ltd., 1-10-6, Shinonome, Koto-ku, Tokyo 135-8558, Japan.
Biomedicines. 2025 Feb 21;13(3):556. doi: 10.3390/biomedicines13030556.
: The skin is an important barrier that protects against invasion by foreign substances and retains water in the body. Several skin diseases involve dry skin due to a disrupted skin barrier, and most skin diseases that appear on dry skin are accompanied by itch. Dry skin-induced itch and mechanical alloknesis reduce quality of life. Sulfated hemicellulose (i.e., pentosan polysulfate sodium), similar to heparin, is a compound belonging to the sulfated polysaccharide family; however, in contrast to heparin, it is derived from plant materials. We herein investigate the effects of the topical application of OJI-204, a sulfated hemicellulose made by purifying and chemically synthesizing hemicellulose, on dry skin in a mouse model. : The mouse model of dry skin was generated using a mixture of acetone and ether with water. Either OJI-204 (3% or 10%) or 0.3% heparinoid, PBS (control), was applied twice a day to the cetone and diethyl ther/ater (AEW)-treated area. The degree of skin dryness was evaluated by measuring transepidermal water loss and stratum corneum hydration. Scratching behavior was recorded the day before AEW treatment and the day after the final day, and an alloknesis assay was performed on the day after the final day. : We found that 3% or 10% OJI-204 attenuated dry skin conditions (erythema/hemorrhage, scarring/dryness, edema, and excoriation/erosion) and itchiness more effectively than 0.3% heparinoid. Furthermore, the degree of dryness improved to the same degree as that with heparinoid. OJI-204 also significantly reduced dry skin-induced spontaneous itch and mechanical alloknesis. : These results suggest the potential of OJI-204 as a therapeutic or preventive agent for dry skin.
皮肤是一道重要的屏障,可防止外来物质入侵并保留体内水分。几种皮肤疾病因皮肤屏障受损而导致皮肤干燥,大多数出现在干性皮肤上的疾病都伴有瘙痒。皮肤干燥引起的瘙痒和机械性异常性疼痛会降低生活质量。硫酸化半纤维素(即戊聚糖多硫酸钠)与肝素类似,是一种属于硫酸化多糖家族的化合物;然而,与肝素不同的是,它来源于植物材料。我们在此研究通过纯化和化学合成半纤维素制成的硫酸化半纤维素OJI - 204局部应用于小鼠干性皮肤模型的效果。
使用丙酮、乙醚和水的混合物建立小鼠干性皮肤模型。将OJI - 204(3%或10%)或0.3%类肝素、PBS(对照)每天两次涂抹于丙酮和乙醚/水(AEW)处理的区域。通过测量经表皮水分流失和角质层水合作用来评估皮肤干燥程度。在AEW处理前一天和最后一天之后记录抓挠行为,并在最后一天之后进行异常性疼痛测定。
我们发现,3%或10%的OJI - 204比0.3%类肝素更有效地减轻了皮肤干燥状况(红斑/出血、瘢痕形成/干燥、水肿和表皮剥脱/糜烂)和瘙痒。此外,干燥程度改善到与类肝素相同的程度。OJI - 204还显著减少了皮肤干燥引起的自发性瘙痒和机械性异常性疼痛。
这些结果表明OJI - 204作为干性皮肤治疗或预防剂的潜力。